Schlessinger Eye & Face is pleased to offer a new vision test to all patients. The purpose of this test is to provide more comprehensive information and to better monitor the effect of your treatment.
The Diopsys® NOVA-VEP Vision Testing System is a painless, non-invasive vision test that objectively measures the function of the entire visual pathway from the eyes to the vision center of the brain. The Diopsys® NOVA device does this by using a technology called Visual Evoked Potential (VEP). VEP has been demonstrated to aid in the diagnosis and treatment of many disorders including amblyopia, brain injury, stroke, multiple sclerosis, and other vision-related issues such as glaucoma. This test will help provide comprehensive information on vision disorders, and better plan your treatment and monitor the results.